Valuation: Safe Fertility Group

Market Cap 1.64B 49.16M 42.66M 39.69M 36.44M 68.86M 4.69B 69.97M 468M 184M 2.34B 185M 181M 7.83B P/E 2026 *
12.9x
P/E 2027 * 11.6x
Enterprise Value 1.64B 49.16M 42.66M 39.69M 36.44M 68.86M 4.69B 69.97M 468M 184M 2.34B 185M 181M 7.83B EV / Sales 2026 *
2.35x
EV / Sales 2027 * 2.13x
Free-Float
23.1%
Yield 2026 *
6.85%
Yield 2027 * 7.41%
05-08 Safe Fertility Group Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
02-20 Safe Fertility Group Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02-19 Safe Fertility Group Public Company Limited announces Annual dividend, payable on May 22, 2026 CI
11-07 Safe Fertility Group Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
07/08/25 Safe Fertility Group Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
07/05/25 Safe Fertility Group Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
29/04/25 Safe Fertility Group Public Company Limited Approves Dividend for the Year 2024, Payable on 23 May 2025 CI
20/02/25 Safe Fertility Group Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024 CI
20/02/25 Safe Fertility Group Public Company Limited announces Annual dividend, payable on May 23, 2025 CI
07/11/24 Safe Fertility Group Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
02/11/24 125,378,468 Ordinary Shares of Safe Fertility Group Public Company Limited are subject to a Lock-Up Agreement Ending on 2-NOV-2024. CI
07/08/24 Safe Fertility Group Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
02/05/24 41,792,822 Ordinary Shares of Safe Fertility Group Public Company Limited are subject to a Lock-Up Agreement Ending on 2-MAY-2024. CI
1 day-0.92%
1 week-2.70%
1 month-5.26%
3 months-13.60%
6 months-8.47%
Current year-14.96%
1 week 5.35
Extreme 5.35
5.6
1 month 5.35
Extreme 5.35
5.85
Current year 5.35
Extreme 5.35
6.9
1 year 5.35
Extreme 5.35
7.95
3 years 5.35
Extreme 5.35
23.7
5 years 5.35
Extreme 5.35
23.7
10 years 5.35
Extreme 5.35
23.7
Manager TitleAgeSince
Chief Executive Officer 60 01/01/2007
Director of Finance/CFO 45 -
Chief Operating Officer 59 20/07/2009
Director TitleAgeSince
Director/Board Member 60 01/01/2007
Director/Board Member 59 20/07/2009
Director/Board Member 59 -
Date Insider Type Main position Quantity % Market Cap.
1/20/26 A Buy

Chief Executive Officer

10,000 0.0033%
1/19/26 A Buy

Chief Executive Officer

62,000 0.0204%
1/12/26 A Buy

Chief Executive Officer

27,500 0.0090%
Change 5-day change 1-year change 3-year change Capi.($)
-0.92%-2.70%-28.00% - 49.09M
-0.75%-3.07%+68.16%+39.82% 133B
+1.72%+5.34%+13.73%+47.57% 87.16B
-0.80%+1.64%+6.05%+56.05% 28.85B
-0.55%+2.26%+39.19%+72.33% 25.72B
-0.63%+9.25%-10.37%-18.69% 21.9B
+0.81%+9.25%+57.97%+240.93% 20.51B
+0.51%+1.98%+71.04%+135.41% 15.41B
+0.64%+3.77%+6.58%-3.78% 14.98B
+0.36%+2.73%-0.07%-5.87% 13.55B
Average +0.04%+3.04%+22.43%+62.64% 36.14B
Weighted average by Cap. +0.10%+1.88%+37.67%+53.73%

Financials

2026 *2027 *
Net sales 698M 20.9M 18.14M 16.88M 15.5M 29.28M 1.99B 29.76M 199M 78.17M 994M 78.5M 76.78M 3.33B 772M 23.12M 20.07M 18.67M 17.14M 32.39M 2.21B 32.91M 220M 86.46M 1.1B 86.83M 84.92M 3.68B
Net income 128M 3.83M 3.33M 3.09M 2.84M 5.37M 366M 5.46M 36.5M 14.34M 182M 14.4M 14.08M 610M 142M 4.24M 3.68M 3.42M 3.14M 5.94M 404M 6.03M 40.35M 15.85M 201M 15.91M 15.56M 675M
Net Debt - -
Logo Safe Fertility Group
Safe Fertility Group Public Company Limited is a Thailand-based company engaged in providing an obstetrics and gynecology hospital. It is also engaged in the business of medical laboratory and cosmetic dermatology. The Company's segments are Obstetrics and Gynecology Hospital and Medical Laboratory, and Cosmetic Dermatology. Its services categories include In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI), Intrauterine Insemination (IUI), Egg Freezing, Embryo Transfer, Sperm Freezing, Sperm Analysis, Magnetic Activated Cell Sorting (MACS) Sperm, Intracytoplasmic Morphologically Selected Sperm Injection (IMSI), Testicular Sperm Extraction/Percutaneous Epididymal Sperm Aspiration (TESE/PESA), Couple Check-Up, EmbryoScope Plus, Preimplantation Genetic Testing for Aneuploidy (PGT-A), Preimplantation Genetic Testing for Monogenic Disorders (PGT-M), and Acupuncture. The Company's subsidiaries include Next Generation Genomics Co., Ltd., and Safe Wellness Company Limited.
Employees
-
Date Price Change Volume
31/07/26 THB 5.400 -0.92% 381,124
30/07/26 THB 5.450 -1.80% 618,232
27/07/26 THB 5.550 -.--% 69,000
24/07/26 THB 5.550 -.--% 112,113
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
5.400THB
Average target price
7.425THB
Spread / Average Target
+37.50%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SAFE Stock